Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges.

Identifieur interne : 002731 ( PubMed/Corpus ); précédent : 002730; suivant : 002732

Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges.

Auteurs : Nicole L. Stout ; Pierre Brantus ; Christine Moffatt

Source :

RBID : pubmed:21360379

English descriptors

Abstract

Lymphoedema is a chronic swelling condition that contributes to disability, dysfunction and lost quality of life. Significant disparities exist worldwide regarding the availability of resources necessary to identify, treat and manage lymphoedema. This disparity transcends socio-economic status and is a common problem in both developed and developing countries. The overall impact of lymphoedema as a public health problem, however, is underestimated, principally due to the lack of epidemiologic data. These problems pose barriers to optimal identification and management of this disabling, lifelong condition. In 1997, the World Health Organization (50.29) resolved that lymphatic filariasis should be eliminated as a public health problem. A component of this strategy focuses on disability management for those suffering from lymphatic filariasis-related morbidity. This initiative has enhanced lymphoedema awareness in developing countries. However, significant deficits persist in health care providers' knowledge, educational initiatives and basic disease identification and treatment. In developed countries, lymphoedema continues to be an underrecognised condition and assumed to be only cancer-related. Health care resources allocated to treat and manage the disease are insufficient for basic and ongoing care, resulting in disease progression and disability. The International Lymphoedema Framework project, established in 2002, seeks to establish a consensus for best practices in the management of lymphoedema worldwide to reduce this disability burden. A basic global construct for lymphoedema management is needed to decrease morbidity and promote optimal disease management across all cultural and socio-economic boundaries. Many countries are unaware of the importance of lymphoedema management and have not defined a national strategy with respect to this problem. The objective of this article is to define similarities and differences in strategies for lymphoedema management between developed and developing countries and advocate for a cohesive and concerted approach to disease management.

DOI: 10.1080/17441692.2010.549140
PubMed: 21360379

Links to Exploration step

pubmed:21360379

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges.</title>
<author>
<name sortKey="Stout, Nicole L" sort="Stout, Nicole L" uniqKey="Stout N" first="Nicole L" last="Stout">Nicole L. Stout</name>
<affiliation>
<nlm:affiliation>Breast Care Department, National Naval Medical Center, Bethesda, MD 20889, USA. Nicole.stout@med.navy.mil</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brantus, Pierre" sort="Brantus, Pierre" uniqKey="Brantus P" first="Pierre" last="Brantus">Pierre Brantus</name>
</author>
<author>
<name sortKey="Moffatt, Christine" sort="Moffatt, Christine" uniqKey="Moffatt C" first="Christine" last="Moffatt">Christine Moffatt</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:21360379</idno>
<idno type="pmid">21360379</idno>
<idno type="doi">10.1080/17441692.2010.549140</idno>
<idno type="wicri:Area/PubMed/Corpus">002731</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002731</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges.</title>
<author>
<name sortKey="Stout, Nicole L" sort="Stout, Nicole L" uniqKey="Stout N" first="Nicole L" last="Stout">Nicole L. Stout</name>
<affiliation>
<nlm:affiliation>Breast Care Department, National Naval Medical Center, Bethesda, MD 20889, USA. Nicole.stout@med.navy.mil</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brantus, Pierre" sort="Brantus, Pierre" uniqKey="Brantus P" first="Pierre" last="Brantus">Pierre Brantus</name>
</author>
<author>
<name sortKey="Moffatt, Christine" sort="Moffatt, Christine" uniqKey="Moffatt C" first="Christine" last="Moffatt">Christine Moffatt</name>
</author>
</analytic>
<series>
<title level="j">Global public health</title>
<idno type="eISSN">1744-1706</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Developed Countries</term>
<term>Developing Countries</term>
<term>Diagnosis, Differential</term>
<term>Early Diagnosis</term>
<term>Health Education</term>
<term>Healthcare Disparities</term>
<term>Humans</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (prevention & control)</term>
<term>Lymphedema (therapy)</term>
<term>Physical Therapy Modalities</term>
<term>Primary Health Care</term>
<term>Public Health</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Developed Countries</term>
<term>Developing Countries</term>
<term>Diagnosis, Differential</term>
<term>Early Diagnosis</term>
<term>Health Education</term>
<term>Healthcare Disparities</term>
<term>Humans</term>
<term>Physical Therapy Modalities</term>
<term>Primary Health Care</term>
<term>Public Health</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lymphoedema is a chronic swelling condition that contributes to disability, dysfunction and lost quality of life. Significant disparities exist worldwide regarding the availability of resources necessary to identify, treat and manage lymphoedema. This disparity transcends socio-economic status and is a common problem in both developed and developing countries. The overall impact of lymphoedema as a public health problem, however, is underestimated, principally due to the lack of epidemiologic data. These problems pose barriers to optimal identification and management of this disabling, lifelong condition. In 1997, the World Health Organization (50.29) resolved that lymphatic filariasis should be eliminated as a public health problem. A component of this strategy focuses on disability management for those suffering from lymphatic filariasis-related morbidity. This initiative has enhanced lymphoedema awareness in developing countries. However, significant deficits persist in health care providers' knowledge, educational initiatives and basic disease identification and treatment. In developed countries, lymphoedema continues to be an underrecognised condition and assumed to be only cancer-related. Health care resources allocated to treat and manage the disease are insufficient for basic and ongoing care, resulting in disease progression and disability. The International Lymphoedema Framework project, established in 2002, seeks to establish a consensus for best practices in the management of lymphoedema worldwide to reduce this disability burden. A basic global construct for lymphoedema management is needed to decrease morbidity and promote optimal disease management across all cultural and socio-economic boundaries. Many countries are unaware of the importance of lymphoedema management and have not defined a national strategy with respect to this problem. The objective of this article is to define similarities and differences in strategies for lymphoedema management between developed and developing countries and advocate for a cohesive and concerted approach to disease management.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21360379</PMID>
<DateCreated>
<Year>2011</Year>
<Month>12</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>05</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2011</Year>
<Month>12</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1744-1706</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>7</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2012</Year>
</PubDate>
</JournalIssue>
<Title>Global public health</Title>
<ISOAbbreviation>Glob Public Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges.</ArticleTitle>
<Pagination>
<MedlinePgn>107-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2010.549140</ELocationID>
<Abstract>
<AbstractText>Lymphoedema is a chronic swelling condition that contributes to disability, dysfunction and lost quality of life. Significant disparities exist worldwide regarding the availability of resources necessary to identify, treat and manage lymphoedema. This disparity transcends socio-economic status and is a common problem in both developed and developing countries. The overall impact of lymphoedema as a public health problem, however, is underestimated, principally due to the lack of epidemiologic data. These problems pose barriers to optimal identification and management of this disabling, lifelong condition. In 1997, the World Health Organization (50.29) resolved that lymphatic filariasis should be eliminated as a public health problem. A component of this strategy focuses on disability management for those suffering from lymphatic filariasis-related morbidity. This initiative has enhanced lymphoedema awareness in developing countries. However, significant deficits persist in health care providers' knowledge, educational initiatives and basic disease identification and treatment. In developed countries, lymphoedema continues to be an underrecognised condition and assumed to be only cancer-related. Health care resources allocated to treat and manage the disease are insufficient for basic and ongoing care, resulting in disease progression and disability. The International Lymphoedema Framework project, established in 2002, seeks to establish a consensus for best practices in the management of lymphoedema worldwide to reduce this disability burden. A basic global construct for lymphoedema management is needed to decrease morbidity and promote optimal disease management across all cultural and socio-economic boundaries. Many countries are unaware of the importance of lymphoedema management and have not defined a national strategy with respect to this problem. The objective of this article is to define similarities and differences in strategies for lymphoedema management between developed and developing countries and advocate for a cohesive and concerted approach to disease management.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stout</LastName>
<ForeName>Nicole L</ForeName>
<Initials>NL</Initials>
<AffiliationInfo>
<Affiliation>Breast Care Department, National Naval Medical Center, Bethesda, MD 20889, USA. Nicole.stout@med.navy.mil</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brantus</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moffatt</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>05</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Glob Public Health</MedlineTA>
<NlmUniqueID>101256323</NlmUniqueID>
<ISSNLinking>1744-1692</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D019049" MajorTopicYN="Y">Developed Countries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006266" MajorTopicYN="N">Health Education</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054625" MajorTopicYN="Y">Healthcare Disparities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D026741" MajorTopicYN="Y">Physical Therapy Modalities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>3</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>3</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>5</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21360379</ArticleId>
<ArticleId IdType="pii">934025072</ArticleId>
<ArticleId IdType="doi">10.1080/17441692.2010.549140</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002731 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002731 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:21360379
   |texte=   Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:21360379" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024